Indication
Portal Vein Tumor Thrombus
2 clinical trials
3 products
1 drug
Clinical trial
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With Portal Vein Tumor ThrombusStatus: Completed, Estimated PCD: 2021-12-30
Product
LenvatinibProduct
SintilimabClinical trial
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus#a Prospective, Multicenter, Single-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2023-02-02
Drug
CadonilimabProduct
Renvatinib